Hormonal Contraception and Breast Cancer Risk

Research output: Contribution to journalArticle

Abstract

Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.

Original languageEnglish (US)
JournalAmerican Journal of Lifestyle Medicine
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Contraception
Breast Neoplasms
Progesterone Congeners
Estrogens

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Hormonal Contraception and Breast Cancer Risk. / White, Nicole D.

In: American Journal of Lifestyle Medicine, 01.01.2018.

Research output: Contribution to journalArticle

@article{91f118af2c90471e8ea172925756c496,
title = "Hormonal Contraception and Breast Cancer Risk",
abstract = "Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.",
author = "White, {Nicole D.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/1559827618754833",
language = "English (US)",
journal = "American Journal of Lifestyle Medicine",
issn = "1559-8276",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Hormonal Contraception and Breast Cancer Risk

AU - White, Nicole D.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.

AB - Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.

UR - http://www.scopus.com/inward/record.url?scp=85041596548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041596548&partnerID=8YFLogxK

U2 - 10.1177/1559827618754833

DO - 10.1177/1559827618754833

M3 - Article

JO - American Journal of Lifestyle Medicine

JF - American Journal of Lifestyle Medicine

SN - 1559-8276

ER -